Date published: 2026-4-23

1-800-457-3801

SCBT Portrait Logo
Seach Input

Cryptic Activators

Cryptic Activators are a diverse class of chemical compounds known for their role in modulating the activity of the protein Cryptic through various biochemical pathways. These activators encompass a range of small molecules, peptides, and other organic compounds that interact with Cryptic, leading to an enhancement of its natural functions within cellular processes. The interactions between Cryptic Activators and the protein can include direct binding to specific domains of Cryptic, resulting in a conformational change that stabilizes the protein's active form. This stabilization allows Cryptic to engage more effectively with its substrates, facilitating a more efficient catalysis of reactions or interactions that it normally undertakes. Additionally, some members of this chemical class function by mimicking post-translational modifications of Cryptic, such as phosphorylation, thereby activating the protein and prolonging its active state by preventing deactivation by cellular phosphatases.

Beyond direct interactions, Cryptic Activators can also exert their effect indirectly by modulating the signaling pathways that influence Cryptic activity. For instance, some activators inhibit kinases or phosphatases that regulate Cryptic, altering the phosphorylation state of the protein and its associated partners within the cell. Others can alter intracellular messenger concentrations, such as cyclic AMP or calcium ions, which in turn activate kinases or other enzymes that work in concert with Cryptic. By manipulating these signaling cascades, Cryptic Activators can help maintain the protein in its active form or enhance its activity. This modulation can influence a variety of cellular processes by altering the dynamics of Cryptic's interactions and its role in the complex network of intracellular signaling.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin activates adenylyl cyclase, leading to increased production of cyclic AMP (cAMP). Higher levels of cAMP enhance the activity of protein kinase A (PKA), which can phosphorylate various proteins indirectly involved in the pathways that Cryptic functions in, thus potentially enhancing Cryptic's functional activity in these pathways.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Genistein is a tyrosine kinase inhibitor that reduces phosphorylation activity, which may result in the enhanced function of Cryptic if tyrosine kinase phosphorylation normally inhibits pathways that Cryptic is involved in. This inhibition can allow Cryptic to function more effectively by reducing competitive or regulatory phosphorylation events.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor that prevents the phosphorylation of PIP2 to PIP3, leading to attenuated Akt signaling. This reduction can indirectly enhance the activity of Cryptic by influencing the downstream signaling events that Cryptic is part of, particularly if Cryptic's activity is upregulated when PI3K/Akt signaling is diminished.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 is an inhibitor of MEK, which in turn inhibits the ERK pathway. By inhibiting this pathway, the activity of Cryptic could be enhanced if Cryptic is involved in a pathway that is negatively regulated by ERK signaling, or if Cryptic functions are favored when ERK signaling is reduced.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a specific inhibitor of p38 MAPK. The inhibition of p38 can lead to the enhancement of Cryptic activity if Cryptic functions in a pathway that is suppressed by p38 activity or if the inhibition of p38 shifts the balance toward signaling pathways that activate Cryptic.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$165.00
$322.00
$570.00
$907.00
$1727.00
7
(1)

Sphingosine-1-phosphate (S1P) activates S1P receptors, which can lead to the activation of several signaling pathways, including those that may enhance the function of Cryptic. S1P signaling could potentially promote cellular processes in which Cryptic is a critical component, thus indirectly increasing Cryptic's functional activity.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Thapsigargin inhibits the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to an increase in cytosolic calcium levels. Elevated calcium can activate calcium-dependent proteins and pathways, potentially enhancing the activity of Cryptic if it is involved in calcium-regulated signaling pathways or processes.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Staurosporine is a broad-spectrum kinase inhibitor, but it could selectively enhance Cryptic pathways by inhibiting kinases that negatively regulate pathways Cryptic is involved in. This inhibition may lift certain restraints on Cryptic, allowing for its enhanced functional activity in those pathways.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

A23187 is an ionophore that increases intracellular calcium levels. This elevation in calcium can activate calcium-dependent signaling pathways, potentially enhancing the activity of Cryptic, especially if Cryptic is regulated by or interacts with calcium-sensitive components within these pathways.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

Epigallocatechin gallate (EGCG) inhibits various kinases, potentially leading to the enhancement of Cryptic activity by relieving negative regulation or competition from these kinases. EGCG may influence pathways that, when inhibited, result in an upregulation of Cryptic's function within the cell.